Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy.

Background And Aims: The outcome of patients with HCC who achieved complete response (CR) to immune-checkpoint inhibitor (ICI)-based systemic therapies is unclear.

Approach And Results: Retrospective study of patients with HCC who had CR according to modified Response Evaluation Criteria in Solid Tumors (CR-mRECIST) to ICI-based systemic therapies from 28 centers in Asia, Europe, and the United States. Of 3933 patients with HCC treated with ICI-based noncurative systemic therapies, 174 (4.

A genome-wide screen identifies silencers with distinct chromatin properties and mechanisms of repression.

Differential gene transcription enables development and homeostasis in all animals and is regulated by two major classes of distal cis-regulatory DNA elements (CREs): enhancers and silencers. Although enhancers have been thoroughly characterized, the properties and mechanisms of silencers remain largely unknown. By an unbiased genome-wide functional screen in Drosophila melanogaster S2 cells, we discover a class of silencers that bind one of three transcription factors (TFs) and are generally not included in chromatin-defined CRE catalogs as they mostly lack detectable DNA accessibility.

Two-Qubit Operations for Finite-Energy Gottesman-Kitaev-Preskill Encodings.

We present techniques for performing two-qubit gates on Gottesman-Kitaev-Preskill (GKP) codes with finite energy, and find that operations designed for ideal infinite-energy codes create undesired entanglement when applied to physically realistic states. We demonstrate that this can be mitigated using recently developed local error-correction protocols, and evaluate the resulting performance. We also propose energy-conserving finite-energy gate implementations which largely avoid the need for further correction.